Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.

Autor: Shudofsky KN; Department of Clinical Pharmacy, VieCuri Medical Center, Venlo, The Netherlands., Janssen PKC; Department of Clinical Pharmacy, VieCuri Medical Center, Venlo, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands., Foudraine N; Department of Intensive Care, VieCuri Medical Center, Venlo, The Netherlands., le Noble JLML; Department of Intensive Care, VieCuri Medical Center, Venlo, The Netherlands.; Department of Pharmacology and Toxicology, UM, Maastricht, The Netherlands.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2022 Apr; Vol. 62 (4), pp. 568-570. Date of Electronic Publication: 2022 Jan 03.

Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease.

Autor: Oshagbemi OA; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht, The Netherlands., Burden AM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht, The Netherlands., Shudofsky KN; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Clinical Pharmacy, Atrium Medical Centre, Heerlen, The Netherlands., Driessen JHM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht, The Netherlands; NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands., Vestergaard P; Departments of Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark., Krings A; Department of Clinical Pharmacy, Atrium Medical Centre, Heerlen, The Netherlands., Franssen FME; Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands., van den Bergh J; Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands; REVAL - Rehabilitation Research Centre and BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium., de Vries F; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht, The Netherlands; MRC Lifecourse Epidemiology Unit, Southampton General Hospital, Southampton, United Kingdom. Electronic address: f.devries@uu.nl.

Publikováno v: Bone [Bone] 2018 May; Vol. 110, pp. 238-243. Date of Electronic Publication: 2018 Feb 17.